Vogel W M, Lieberthal W, Apstein C S, Levinsky N, Valeri C R
Naval Blood Research Laboratory, Boston University School of Medicine, Massachusetts.
Biomater Artif Cells Artif Organs. 1988;16(1-3):227-35. doi: 10.3109/10731198809132572.
"Stroma-free" hemoglobin solutions (SFH) cause hemodynamic alterations indicative of vasoconstriction. We studied vasoconstrictor activity in isolated rabbit hearts and rat kidneys of unmodified SFH and of SFH modified by pyridoxylation or glyoxylation, with or without glutaraldehyde cross-linking. The purity and chemical composition of the solutions, all prepared by other laboratories, were not characterized by us. In isolated hearts SFH prepared by conventional methods had potent vasoconstrictor activity. Pyridoxylation or purification by ion exchange chromatography did not alter the constrictor activity. Decreased constrictor activity was observed with human SFH cross-linked by glutaraldehyde treatment, or purified by affinity chromatography, and with bovine SFH purified by ultrafiltration and preparative HPLC. In isolated kidneys modified and unmodified SFH increased renal vascular resistance and decreased glomerular filtration rate with no morphologic evidence of tubular damage.
“无基质”血红蛋白溶液(SFH)会引起提示血管收缩的血流动力学改变。我们研究了未修饰的SFH以及经吡哆醛化或乙二醛化修饰(有无戊二醛交联)的SFH在离体兔心脏和大鼠肾脏中的血管收缩活性。这些溶液均由其他实验室制备,其纯度和化学成分未由我们进行鉴定。在离体心脏中,常规方法制备的SFH具有强大的血管收缩活性。吡哆醛化或通过离子交换色谱法纯化并未改变其收缩活性。经戊二醛处理交联的人SFH、通过亲和色谱法纯化的人SFH以及通过超滤和制备型高效液相色谱法纯化的牛SFH,其收缩活性均降低。在离体肾脏中,修饰和未修饰的SFH均增加肾血管阻力并降低肾小球滤过率,且无肾小管损伤的形态学证据。